Delivery Order SPE2DB24D2208-SPE2DB24FHGWT

Award Date 7/3/24
Potential Completion Date 7/5/24
Potential Value $14K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,478,068 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $7,065.42 and a completion date of January 3, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,565,135 units of Ondansetron HCL 4 MG Tablet, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $50,818.06 and a period of performance through July 15, 2024. This delivery order is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,090,414 units of Ondansetron HCL 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a ceiling value of $47,037.51 and a completion date of January 30, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $19,991.66, is for the delivery of 4,566,405,648 units of Ondansetron HCl 4 mg Tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price and an ultimate completion date of November 13, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,563,866,919 units of Ondansetron HCL 8 mg tablets, a medication commonly used to treat nausea and vomiting. The firm-fixed-price contract has a ceiling value of $5,111.82 and a period of performance through March 6, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,178.92, is for the delivery of 4,562,459,098 units of Ondansetron HCL 4 mg tablets, a medication commonly used to treat nausea and vomiting. The contract has an ultimate completion date of October 13, 2023 and is a firm fixed-price delivery order, with no...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,565,425,639 units of Ondansetron ODT 8 mg tablets, a medication commonly used to treat nausea and vomiting. The delivery order is valued at $1,085.14 and has a firm fixed price. The contract has an ultimate completion date of August 13, 2024 and was awarded on August 12, 2024. This delivery order is likely part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,296,427 units of Ondansetron ODT 4 MG tablets, a medication used to treat nausea and vomiting. The contract has a firm fixed price of $15,175.16 and a performance period ending on July 31, 2024. This delivery order is placed under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,222,794 units of Ondansetron HCL 4 mg tablets, a medication commonly used to prevent nausea and vomiting. The contract has a total ceiling value of $14,687.87 and runs through February 11, 2025. This contract is not designated as a set-aside contract. AmerisourceBergen holds...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ondansetron ODT 4 mg tablets, a medication used to prevent nausea and vomiting. The contract has a total ceiling value of $11,126.30 and an ultimate completion date of December 30, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract...
  • SPE2DB24D2208
    Indefinite Delivery Contract
  • SPE2DB24D2208-SPE2DB24FHGWT
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the delivery of 4,565,069,737 units of Ondansetron HCL 4 mg tablets, a medication used to treat nausea and vomiting. The contract has a ceiling value of $14,358.35 and a period of performance through July 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies for military treatment programs and facilities worldwide. This specific delivery order does not have a set-aside designation.

Generated 10/2/24, 9:44 AM